Data as of Nov 6, 2026
64.79.138.0/24
No anonymizer space · no proxy exits in 30 daysSwitch, Ltd
Announcements
Less specific
Covering announcements
| Prefix | Origin | Type | Proxy exits | Holder | RPKI |
|---|---|---|---|---|---|
| 64.79.128.0/19 since Nov 2007 | AS23005 | Hosting | 9 | Switch, Ltd |
Registrations in this block
The registry's network records over the announcement: those covering it, widest first, then every record inside it, under its parent.
| Range | Addresses | Netname | Holder | Type | Created | Abuse contact |
|---|---|---|---|---|---|---|
| 64.79.128.0/19 | 8,192 | SWITCH-LTD | Switch, Ltd (SWITC-2) · US | Direct Allocation | Mar 21, 2006 | abuse@ |
| └ 64.79.138.0/24 | 256 | ENTITSOFTWARELLCSUBSIDIARYOFMICROFOCUS-138 | Hewlett Packard Corporation (HPC-93) · US | Reassigned | Apr 17, 2019 | — |
Network & registry
IPv4 market
Holder
- Organization
- Switch, Ltd
- Handle
- SWITC-2
- Range
- 64.
79. 128. 0/ 19 - Registration type
- Direct Allocation
- Record created
- Mar 21, 2006
Origin network
AS23005
US
- Name
- Switch, Ltd
- Type
- Hosting
- Registered
- Dec 28, 2001
- Domain
- switch.com
- Spamhaus ASN-DROP
- not listed
- VPN servers
- 13
Routing timeline
Covering aggregate above, the prefix's own history below
Summary
Routing history
- Pattern
- Rotating
- First seen
- Jun 2010
- Current origin since
- Jul 2025 · 1.3 yr
- Origin networks
- 2
- Last change of origin
- Jul 2025
Recorded history
History
- Handoffs
- 2
Whois
Registration for this announcement
- Range
- 64.
79. 138. 0/ 24 - Netname
- ENTITSOFTWARELLCSUBSIDIARYOFMICROFOCUS-138
- Registrant
- Hewlett Packard Corporation
- Organization
- Hewlett Packard Corporation (HPC-93)
- Org address
- 5758 W. Las Positas, Pleasanton, CA, 94588
- Org country
- US
- Type
- Reassigned
- Handle
- NET-64-79-138-0-1
- Parent
- NET-64-79-128-0-1
- Created
- Apr 17, 2019
- RIR
- ARIN
- Country
- US
- Delegated
- Mar 21, 2006
- Status
- assigned
Report abuse
Abuse contact
- abuse@
switch. com - Name
- AS23005 Abuse
- Phone
- +1-702-267-6602
- Handle
- ASABU2-ARIN